FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

316111000001104: Innovace 10mg tablets (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1738141000001112 Innovace 10mg tablets (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1738151000001110 Innovace 10mg tablets (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Is a Product containing precisely enalapril maleate 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has active ingredient Enalapril maleate false Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Is a Innovace true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has specific active ingredient Enalapril maleate true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Innovace 10mg tablets (Organon Pharma (UK) Ltd) 28 tablet 4 x 7 tablets Is pack of False Innovace 10mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Innovace 10mg tablets (Organon Pharma (UK) Ltd) 28 tablet 4 x 7 tablets Has AMP True Innovace 10mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start